Most of what medicine does, it does after something breaks. I have spent my career trying to work the other direction: find the weak spot in your terrain before it becomes a diagnosis, and shore it up while it is still easy. That is exactly what the Neo7 Resilience pathway is built for. It is not for a disease. It is for the person sitting across from me who says, “I feel fine, but I watched my mother decline, and I do not want to wait until something is wrong.” I have written about how I use Neo7 for cancer, for autoimmune and complex chronic illness, stroke and brain recovery, and post-viral illness, and for advanced cancer. This post is the one for the well. It is about aging on purpose instead of by default.
What the Resilience pathway is
Neo7 Bioscience runs four programs: Cancer, Active Disease, SpikeX, and Resilience. The first three are for people who are already facing something. Resilience is the one for prevention, longevity, cognition, energy, and performance — the person who is not sick but wants to know what their biology is actually doing and where it is drifting.
It works the same way the rest of the platform does. You give blood and urine. Neo7 reads several layers of you at once — your DNA, the genes your body is actively expressing through RNA, the proteins you are producing, and your HLA type, which is how your immune cells recognize what to act on. From that, Neo7 designs a small, personalized set of peptides built to fit you. On the Resilience pathway that is about four patient-specific targets, and peptides are usually ready in about six to seven weeks, with repeat testing roughly every four to five months so we can see whether your biology is moving in the right direction.
The point I want you to hold onto: this is not a shelf product. There is no “longevity stack” everyone gets. Two fifty-year-olds who both feel great can have completely different things pushing on them under the surface, so they get two different designs.
The eight hallmarks of aging Neo7 scores
Aging is not one thing. Researchers describe it as a set of connected processes, and Neo7 scores eight of them from your data so we can see which ones are moving fastest in you. In plain language:
Telomere maintenance — the protective caps on the ends of your chromosomes that shorten over time.
Inflammation and immune regulation — whether your immune system is calm and balanced or quietly running hot.
Mitochondrial stress — how well the little engines inside your cells are making energy.
DNA repair — how well your cells fix the everyday damage to their own code.
Oncogenic potential — early molecular signals of cells drifting toward abnormal growth.
Senescent-cell burden — worn-out cells that have stopped dividing but will not clear and give off inflammatory signals.
Autophagy — your cells’ recycling system that clears out broken parts so new ones can be built.
Metabolic and hormone regulation — how your blood sugar, insulin, and hormones are holding their balance.
Seeing them side by side is the part patients find genuinely useful. You stop guessing about “anti-aging” in the abstract and start looking at the two or three processes that are actually ahead of your calendar age — the ones worth spending your effort on.
What your Resilience report shows
Neo7 calls it the Health Index report, and I read it with you. On the Resilience pathway it shows:
A score for each of the eight hallmarks, drawn as a histogram so you can see at a glance where your biology is favorable and where it is not.
An expression table — which of the targets Neo7 is watching are running too high or too low in you, and whether that reading is favorable or not.
Your personalized targets and the peptides designed for them, each tied to the hallmark it addresses and the published science behind it, so I can tell you exactly why each one is in your plan.
Your HLA typing, confirmed across your samples, because every peptide is built to fit your immune system specifically.
A hub strategy — Neo7 draws your plan as a wheel, with the peptides at the center and everything else you are doing as the spokes: nutrition, targeted supplements, IV and nutrient support, metabolic and inflammation guidance, and the rest. It shows how the pieces fit together.
That last piece is why this belongs in a root-cause practice and not a peptide vending machine. The report does not just hand me four peptides. It hands me a map of your terrain — and the terrain is what I already treat.
Why I like this for the right person
I spend most of my days with people who are already deep in something hard. The Resilience pathway lets me do the thing I most wish I could do more of: get ahead of it. It fits the way I already think — root cause instead of symptom, optimal instead of merely “normal,” your own baseline instead of a population average. A standard lab panel can come back “normal” while three of your aging processes are quietly accelerating. This is a way to see that early, and to aim support where your biology actually needs it instead of where a supplement company’s marketing points.
It also fits something I believe plainly: everyone has a right to feel well and to live their best life. You do not have to earn that with a diagnosis first.
What people say about Neo7
These are reviews people have posted on Neo7 Bioscience’s Success Stories page. They are individual experiences, shared in each person’s own words, and they are not promises — one person’s story does not predict yours, and results vary.
Ivette S. describes “a very innovative and remarkable approach to wellness, disease treatment and promotion of resilience in a person’s health,” and calls it “a targeted personalized method.” Asheley W. writes that Neo7 “developed a personalized peptide built specifically for me, grounded in real science, not a generic plan handed to every patient.” And Ryan M., after years of trying “everything” from diet changes on, describes “steady, real, measurable change that has brought relief I’ve been seeking for years.” I share these not as evidence that it will work for you, but because they describe the thing I care about: personal, measured, and real to the person living it.
Who it is for — and what it is not
The Resilience pathway is a good fit if you are generally well and want to be proactive: a family history that worries you, a decade you want to protect your brain and energy through, a performance goal, or simply the wish to age on your own terms with data instead of guesswork.
Here is what it is, and what it is not. Neo7 therapies are developed under an IRB-governed framework as N-of-1 designs — built for one person — and they are not FDA-approved. The peptides are made at a cGMP-compliant compounding pharmacy and dispensed only on a prescription from a licensed provider; Neo7 reports no serious adverse effects through its program since 2019, with a low-and-slow, HLA-matched start for every patient. What the Resilience pathway gives you is a detailed, personalized read on how you are aging and a plan built around it. It is not a fountain of youth, I will not tell you it reverses aging, and the hallmark scores are Neo7’s own molecular index, not a promise of added years. It is measurement plus targeted support — which, done early and consistently inside a real plan, is a genuinely good bet. I would rather give you that than a story.
How to start
If you want to know how you are aging while there is still the most room to act, book a visit. Bring your history, your family history, your goals, any recent labs, and your supplement list. We look at all of it together, decide whether the Resilience pathway fits you, and if it does, we start with your data instead of a guess. I see patients in person at Rayma Health in Minnetonka, Minnesota. You can also message me through the patient portal or call the office at (612) 324-6338.
We read the terrain, we add the right tools with a reason, and we give your body every chance to stay well. Living your best life is not something you should have to wait for permission to pursue.
Book a consultation · Call (612) 324-6338 · Rayma Health, Minnetonka, Minnesota
Frequently asked questions
Do I have to be sick to use Neo7?
No. The Resilience pathway is specifically for people who are well and want to stay that way. Neo7 runs four pathways — Cancer, Active Disease, SpikeX, and Resilience — and Resilience is the prevention, longevity, and performance one.
What does the Resilience pathway test?
Blood and urine. From those, Neo7 reads your DNA, RNA, proteins, and HLA type and scores eight hallmarks of aging, then designs about four peptides matched to you.
Is this a biological age test?
It is more than a single number. Instead of one “age,” it scores eight separate aging processes so you can see which ones are moving fastest in you, and it pairs that with a personalized plan. We re-test roughly every four to five months to watch the trend.
How long until I start, and how is it given?
Peptides are usually ready in about six to seven weeks. They are small injections under the skin or into the muscle, most of them self-given at home after a short training.
Will it reverse aging?
I will not tell you that. Neo7 scores how you are aging and designs support around your weakest areas; the real goal is to measure the right processes and nudge them in a better direction early, inside a full plan. No outcome is promised.
Is Neo7 FDA-approved?
No. Neo7 therapies are developed under an IRB-governed framework as N-of-1 designs and are prescribed by a licensed provider. The peptides are made at a cGMP-compliant compounding pharmacy on a valid prescription.
Can I order it myself?
No. A licensed prescriber is required for every pathway. I order the testing, read the report with you, prescribe the peptides, and oversee the plan.
How does it fit the rest of what I do?
It is added to your plan, not swapped in for it. The report’s hub strategy shows how the peptides, your nutrition, your supplements, and any other support fit together. Nothing you are already doing has to stop.
Alicia Hickson, MSPAS, PA-C is a board-certified physician assistant, Certified Functional Medicine Practitioner, and the founder of Rayma Health in Minnetonka, Minnesota. She trained in metabolic oncology under Dr. Thomas Seyfried and in Nasha Winters’ MAPC program, and is Bredesen-certified for cognitive decline. She treats complex chronic illness as a whole person: body, mind, and spirit.
More about Alicia · Medically reviewed by Alicia Hickson, MSPAS, PA-C on 2026-11-19
Read next
Educational content, not personal medical advice. Neo7 peptide therapy is prescribed under an IRB-governed framework and is not FDA-approved; no outcome is promised, and one person’s result does not predict another’s. Alicia Hickson prescribes Neo7 at Rayma Health. Company facts, pathway details, report elements, and the hallmarks scored are Neo7 Bioscience’s, summarized here with attribution; the testimonials are individual experiences published on Neo7 Bioscience’s Success Stories page, not typical results. Neo7, PBIMA, and SpikeX are trademarks of Neo7Bioscience, Inc. Bring your questions to a visit so we can look at your history and your plan together.
Sources (verified 2026-11-19)
Neo7Bioscience website, Patients: the four pathways including Resilience (prevention, longevity, cognition, energy, performance); blood and urine sampling; four patient-specific targets; about six to seven weeks to peptides; repeat testing every four to five months; N-of-1 approach; a licensed prescriber required; routes of administration and home self-injection; “no serious adverse effects through its program since 2019.”
Neo7Bioscience website, Home: the data layers (DNA, RNA, proteomics, HLA) and PBIMA.
Neo7Bioscience website, Success Stories: patient and reviewer testimonials (Ivette S., Asheley W., Ryan M.), read 2026-11-04; quoted verbatim, names shortened, presented as individual experiences.
Neo7Bioscience. Molecular Surveillance and Personalized Engineering Overview (Provider Presentation, 2025/2026): the Resilience Health Index report — the eight hallmarks of aging (telomere maintenance, inflammation and immune regulation, mitochondrial stress, DNA repair, oncogenic potential, senescent-cell burden, autophagy, metabolic and hormone regulation), the hallmark histograms and expression table, target table with peptide sequences and references, HLA allele typing, and the strategic hub wheel.
Neo7Bioscience. The Neo7 Precision Approach to Cancer Care (provider document, 2026): the multi-omic layers, the hub strategy, IRB-based and not FDA-approved N-of-1 design, and cGMP-compliant manufacturing and dispensing on prescription.